These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38867)

  • 1. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
    Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S
    Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
    Akiyama K; Nagao T; Yamamoto M; Fujimoto A; Ebara T; Sato M; Otsuki S
    Folia Psychiatr Neurol Jpn; 1983; 37(2):129-35. PubMed ID: 6200411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF levels of cyclic nucleotides and adrenergic metabolites in malignant gliomas.
    Gerosa MA; Olivi A; Longatti PL; Teolato S; Carteri A
    Surg Neurol; 1980 May; 13(5):359-62. PubMed ID: 6155709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of cyclic nucleotides and monoaminergic metabolites in subarachnoid haemorrhage: preliminary report.
    Gerosa MA; Olivi A; Longatti PL; Teolato A; Carteri A
    Neurochirurgia (Stuttg); 1981 Mar; 24(2):64-6. PubMed ID: 6163998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
    Fujimoto A
    Seishin Shinkeigaku Zasshi; 1980; 82(5):275-91. PubMed ID: 6157171
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism.
    Arató M; Bagdy G; Perényi A; Béla A
    Psychiatry Res; 1984 Apr; 11(4):347-51. PubMed ID: 6146151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
    Jeste DV; Doongaji DR; Linnoila M
    Br J Psychiatry; 1984 Feb; 144():177-80. PubMed ID: 6200172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF neurochemical study of tardive dyskinesia.
    Lu RB; Ko HC; Lin WL; Lin YT; Ho SL
    Biol Psychiatry; 1989 Mar; 25(6):717-24. PubMed ID: 2466490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
    Roccatagliata G; Albano C; Besio G
    Riv Patol Nerv Ment; 1978 Sep; 98(4):228-32. PubMed ID: 33440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probenecid-induced accumulation of cyclic nucleotides, 5-hydroxyindoleacetic acid, and homovanillic acid in cisternal spinal fluid of genetically nervous dogs.
    Angel C; Deluca DC; Murphree OD
    Biol Psychiatry; 1976 Dec; 11(6):743-53. PubMed ID: 187258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.